Sign Up
A 10475 New York Assembly · 2021 Regular Session

Requires the Superintendent of Financial Services to refer the drug insulin to the Drug Accountability Board for examination related to price increases and consumer impact

Summary
Requires the Superintendent of Financial Services to refer the drug insulin to the Drug Accountability Board for examination related to price increases and consumer impact.
Bill status passed 3 of 5 stages cleared
Introduction
May 2022
Committee Review
Jun 2022
Assembly Passage
Jun 2022
Senate Passage
Governor
Introduced May 27, 2022 Last action Jun 3, 2022
Floor votes · Assembly Jun 3, 2022

How they voted

136–0
Passed · 1 other
Total votes 137
Jun 3, 2022
D Democratic98
97 Yea 1
98% Yea
R Republican39
39 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
9
Key actions
1
Committee
4
Jun 3, 2022
Committee
REFERRED TO RULES
upper
Jun 3, 2022
Lower · Passed
PASSED ASSEMBLY
lower
Jun 1, 2022
Committee
REPORTED REFERRED TO RULES
lower
May 31, 2022
Committee
REFERENCE CHANGED TO WAYS AND MEANS
lower
May 27, 2022
Committee
REFERRED TO INSURANCE
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.